Delek US (DK) Financials

$13.78 -0.01 (-0.07%)

Closing price 05/5/2025 03:59 PM Eastern

Extended Trading

$13.85 +0.07 (+0.51%)

As of 04:00 AM Eastern

Annual Income Statements for Delek US

This table shows Delek US's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	19	-154	289	340	311	-611	-128	257	20	-560
Consolidated Net Income / (Loss)	44	-133	323	375	336	-574	-95	291	47	-521
Net Income / (Loss) Continuing Operations	37	-220	329	384	331	-574	-95	265	20	-598
Total Pre-Tax Income	21	-391	299	486	403	-767	-137	322	17	-706
Total Operating Income	69	-49	180	612	492	-732	-35	458	245	-492
Total Gross Profit	545	32	432	973	890	-261	251	748	549	-43
Total Revenue	4,782	4,198	7,267	10,233	9,298	7,302	10,648	19,801	16,467	11,852
Operating Revenue	4,782	4,198	7,267	10,233	9,298	7,302	10,648	19,801	16,467	11,852
Total Cost of Revenue	4,237	4,166	6,835	9,260	8,408	7,563	10,398	19,053	15,919	11,895
Operating Cost of Revenue	4,237	4,166	6,835	9,260	8,408	7,563	10,398	19,053	15,919	11,895
Total Operating Expenses	476	81	251	361	398	471	285	290	304	448
Selling, General & Admin Expense	371	106	176	248	275	235	200	314	272	253
Depreciation Expense	106	10	21	38	24	26	25	11	17	25
Other Operating Expenses / (Income)	-0.50	7.10	54	75	100	85	83	-3.50	-2.50	-52
Impairment Charge	-	0.00	0.00	0.00	0.00	126	0.00	0.00	38	244
Other Special Charges / (Income)	0.00	-42	-	-	-	0.00	-23	-31	-20	-21
Total Other Income / (Expense), net	-47	-342	119	-126	-90	-35	-103	-136	-228	-215
Interest & Investment Income	3.10	-287	17	16	46	30	18	-138	-232	-221
Other Income / (Expense), net	1.60	-0.40	196	-6.90	-4.10	60	16	2.40	3.70	6.30
Income Tax Expense	-16	-172	-29	102	72	-194	-42	56	-3.00	-108
Net Income / (Loss) Discontinued Operations	6.60	86	-5.90	-8.70	5.20	-	-	25	27	77
Net Income / (Loss) Attributable to Noncontrolling Interest	24	20	34	35	26	38	33	33	27	40
Basic Earnings per Share	$0.32	($2.49)	$4.04	$4.11	$4.10	($8.31)	($1.73)	$3.63	$0.30	($8.77)
Weighted Average Basic Shares Outstanding	60.82M	61.92M	71.57M	82.80M	75.85M	73.60M	73.98M	70.79M	65.41M	63.88M
Diluted Earnings per Share	$0.32	($2.49)	$4.00	$3.95	$4.06	($8.31)	($1.73)	$3.59	$0.30	($8.77)
Weighted Average Diluted Shares Outstanding	61.32M	61.92M	72.30M	86.77M	76.57M	73.60M	73.98M	71.52M	65.41M	63.88M
Weighted Average Basic & Diluted Shares Outstanding	-	-	83.92M	78.01M	73.41M	73.78M	74.20M	66.94M	64.02M	62.51M
Cash Dividends to Common per Share	$0.60	$0.60	$0.60	$0.96	$1.14	$0.93	$0.00	$0.61	$0.93	$1.01

This table shows Delek US's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	7.40	-119	64	-8.30	129	-165	-33	-37	-77	-414
Consolidated Net Income / (Loss)	17	-110	72	-1.50	136	-160	-25	-26	-68	-402
Net Income / (Loss) Continuing Operations	17	-135	72	-1.50	126	-177	-25	-26	-135	-412
Total Pre-Tax Income	21	-186	88	-5.30	155	-221	-32	-34	-175	-465
Total Operating Income	53	-136	143	50	212	-160	33	14	-122	-416
Total Gross Profit	141	-139	237	158	278	-124	130	57	-20	-210
Total Revenue	5,325	4,034	3,924	4,196	4,629	3,719	3,228	3,422	3,042	2,161
Operating Revenue	5,325	4,034	3,924	4,196	4,629	3,719	3,228	3,422	3,042	2,161
Total Cost of Revenue	5,184	4,174	3,687	4,038	4,351	3,843	3,098	3,365	3,063	2,370
Operating Cost of Revenue	5,184	4,174	3,687	4,038	4,351	3,843	3,098	3,365	3,063	2,370
Total Operating Expenses	88	-3.90	94	108	66	36	97	43	102	206
Selling, General & Admin Expense	59	82	72	76	68	57	64	63	70	55
Depreciation Expense	6.40	-6.00	6.60	6.80	4.00	-0.70	8.80	11	5.60	-1.00
Other Operating Expenses / (Income)	22	-49	16	25	-5.80	-38	24	-54	17	-39
Total Other Income / (Expense), net	-32	-50	-55	-55	-57	-61	-65	-47	-53	-49
Interest & Investment Income	18	-183	15	26	-55	-217	22	30	-54	-219
Other Income / (Expense), net	0.70	-0.60	7.10	-0.50	-2.00	-0.90	0.70	0.00	0.50	5.10
Income Tax Expense	4.00	-51	16	-3.80	29	-44	-7.20	-7.70	-40	-53
Net Income / (Loss) Attributable to Noncontrolling Interest	9.40	9.00	7.90	6.80	7.40	4.80	7.40	11	9.30	12
Basic Earnings per Share	$0.11	($1.68)	$0.96	($0.13)	$1.98	($2.51)	($0.51)	($0.58)	($1.20)	($6.48)
Weighted Average Basic Shares Outstanding	70.47M	70.79M	66.95M	65.77M	64.89M	65.41M	64.02M	64.21M	64.06M	63.88M
Diluted Earnings per Share	$0.10	($1.65)	$0.95	($0.13)	$1.97	($2.49)	($0.51)	($0.58)	($1.20)	($6.48)
Weighted Average Diluted Shares Outstanding	71.11M	71.52M	67.37M	65.77M	65.46M	65.41M	64.02M	64.21M	64.06M	63.88M
Weighted Average Basic & Diluted Shares Outstanding	69.69M	66.94M	65.73M	64.82M	63.93M	64.02M	64.13M	64.54M	63.20M	62.51M

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-142	387	253	137	-124	-168	69	-15	-19	-87
Net Cash From Operating Activities	180	248	320	560	575	-283	371	425	1,014	-67
Net Cash From Continuing Operating Activities	144	235	322	590	575	-283	371	394	979	-84
Net Income / (Loss) Continuing Operations	37	-220	329	375	336	-574	-95	265	20	-598
Consolidated Net Income / (Loss)	44	-133	323	375	336	-574	-95	291	47	-521
Net Income / (Loss) Discontinued Operations	6.60	86	-5.90	-	-	-	-	25	27	77
Depreciation Expense	106	116	153	199	194	268	265	275	340	375
Non-Cash Adjustments To Reconcile Net Income	-4.50	366	-24	-85	101	2.10	284	167	-87	294
Changes in Operating Assets and Liabilities, net	1.30	-32	-136	101	-56	21	-82	-314	707	-154
Net Cash From Discontinued Operating Activities	36	13	-2.10	-30	-	-	-	32	35	17
Net Cash From Investing Activities	-460	201	38	-125	-691	-191	-178	-932	-408	-242
Net Cash From Continuing Investing Activities	-435	-88	25	-145	-691	-191	-178	-901	-382	-603
Purchase of Property, Plant & Equipment	-188	-46	-172	-322	-413	-269	-222	-280	-393	-428
Acquisitions	-249	-62	185	-1.90	-287	-34	-2.70	-631	-4.30	-205
Purchase of Investments	-	-	-	-	-	-	0.00	0.00	-12	-0.40
Sale of Property, Plant & Equipment	1.20	0.20	0.10	67	16	0.20	12	0.20	1.90	10
Sale and/or Maturity of Investments	-	20	12	1.20	0.80	72	10	9.90	15	5.00
Other Investing Activities, net	-	-	0.00	0.00	-8.00	0.00	24	0.00	10	14
Net Cash From Discontinued Investing Activities	-25	289	12	20	-	-	-	-30	-26	362
Net Cash From Financing Activities	139	-62	-105	-298	-7.90	306	-124	491	-625	222
Net Cash From Continuing Financing Activities	91	-44	-105	-298	-7.90	306	-124	491	-625	222
Repayment of Debt	-417	-385	-1,350	-2,520	-1,590	-1,922	-2,755	-4,831	-5,226	-8,928
Repurchase of Preferred Equity	-	-	-	-	-	-	-	0.00	0.00	-71
Repurchase of Common Equity	-42	-6.00	-25	-365	-178	-1.90	0.00	-194	-85	-42
Payment of Dividends	-58	-62	-87	-80	-87	-98	0.00	-79	-60	-64
Issuance of Debt	612	409	1,408	2,815	1,869	2,068	1,739	4,635	3,546	7,981
Issuance of Common Equity	-	-	-	-	0.00	0.00	0.00	3.10	0.00	298
Other Financing Activities, net	-2.90	-1.10	-51	-148	-23	260	892	956	1,202	1,047
Cash Interest Paid	49	52	82	120	126	124	125	189	329	305
Cash Income Taxes Paid	5.10	1.70	71	104	94	3.60	4.20	28	11	3.80

This table details how cash moves in and out of Delek US's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-91	-313	24	-43	80	-80	-69	-96	380	-302
Net Cash From Operating Activities	130	-291	395	95	433	91	167	-48	-22	-164
Net Cash From Continuing Operating Activities	130	-322	395	95	402	87	167	-48	-39	-163
Net Income / (Loss) Continuing Operations	17	-135	72	-1.50	112	-163	-25	-26	-146	-401
Consolidated Net Income / (Loss)	17	-110	72	-1.50	136	-160	-25	-26	-68	-402
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	3.20	-	-	-	-1.00
Depreciation Expense	73	66	83	89	82	84	95	92	91	96
Non-Cash Adjustments To Reconcile Net Income	-120	45	-50	-104	74	-8.00	102	-2.80	-76	270
Changes in Operating Assets and Liabilities, net	161	-298	289	111	133	174	-5.60	-112	91	-128
Net Cash From Discontinued Operating Activities	-	-	-	-	-	3.50	-	-	-	-0.90
Net Cash From Investing Activities	-99	-112	-222	-58	-59	-69	-42	-63	78	-216
Net Cash From Continuing Investing Activities	-99	-82	-222	-58	-41	-61	-42	-63	-283	-216
Purchase of Property, Plant & Equipment	-95	-87	-211	-66	-43	-72	-47	-86	-104	-191
Acquisitions	-4.40	-1.30	-0.60	-0.70	-1.30	-1.70	-0.70	-0.60	-178	-25
Purchase of Investments	-	-	-7.50	-1.50	-2.00	-0.90	0.00	-0.40	-0.30	0.30
Sale of Property, Plant & Equipment	0.10	-1.00	-	-	0.60	0.60	-	-	1.10	-0.40
Sale and/or Maturity of Investments	-	8.20	2.10	5.20	3.20	4.40	2.80	0.60	0.70	0.90
Other Investing Activities, net	-	-	-4.80	4.80	1.50	8.80	3.60	14	-2.50	-1.30
Net Cash From Financing Activities	-122	90	-149	-81	-294	-101	-194	15	323	77
Net Cash From Continuing Financing Activities	-122	90	-149	-81	-294	-101	-194	15	323	77
Repayment of Debt	-380	-3,065	-1,366	-1,033	-1,564	-1,265	-2,544	-1,832	-2,047	-2,505
Repurchase of Common Equity	-40	-90	-0.40	-40	-25	-20	0.00	-	-20	-22
Payment of Dividends	-28	-51	-24	-25	3.90	-15	-26	-6.20	-16	-16
Issuance of Debt	101	3,064	849	698	1,068	930	2,143	1,723	2,734	1,382
Issuance of Common Equity	-	-	0.00	-	-	-	132	-0.10	-	166
Other Financing Activities, net	226	228	392	318	222	269	100	131	-328	1,143
Cash Interest Paid	38	75	106	54	72	97	75	70	88	71
Cash Income Taxes Paid	17	1.10	0.10	6.50	1.70	2.50	0.00	3.20	0.30	0.30

This table presents Delek US's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	2,980	5,935	5,761	7,016	6,134	6,813	8,193	7,172	6,666
Total Current Assets	1,397	2,612	2,420	2,963	2,300	3,020	3,717	2,666	2,332
Cash & Equivalents	689	932	1,079	955	788	857	841	822	736
Accounts Receivable	266	582	514	793	528	777	1,234	784	618
Inventories, net	392	808	678	947	728	1,261	1,519	941	893
Other Current Assets	49	130	149	269	256	126	123	78	86
Other Current Nonoperating Assets	0.00	160	-	-	-	-	-	42	0.00
Plant, Property, & Equipment, net	1,103	2,141	2,195	2,428	2,367	2,307	2,776	2,696	2,940
Plant, Property & Equipment, gross	1,588	2,773	3,000	3,363	3,520	3,645	4,349	4,460	4,948
Accumulated Depreciation	484	632	805	935	1,152	1,338	1,573	1,764	2,008
Total Noncurrent Assets	480	1,183	1,145	1,625	1,467	1,486	1,700	1,810	1,394
Long-Term Investments	360	138	130	407	364	344	360	361	393
Goodwill	12	817	858	856	730	730	744	688	475
Intangible Assets	27	101	104	110	108	103	316	288	322
Other Noncurrent Operating Assets	81	127	53	251	266	309	280	246	204
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	228	0.00
Total Liabilities & Shareholders' Equity	2,980	5,935	5,761	7,016	6,134	6,813	8,193	7,172	6,666
Total Liabilities	1,797	3,971	3,953	5,181	5,009	5,799	7,123	6,212	6,091
Total Current Liabilities	935	2,672	1,664	2,356	1,903	3,127	3,086	2,685	2,516
Short-Term Debt	84	590	32	36	33	92	75	45	9.50
Accounts Payable	496	975	1,011	1,600	1,144	1,695	1,746	1,814	1,814
Other Current Liabilities	354	1,001	620	720	726	1,339	1,266	815	693
Other Current Nonoperating Liabilities	0.00	106	-	-	-	-	-	12	0.00
Total Noncurrent Liabilities	862	1,299	2,289	2,825	3,106	2,672	4,037	3,527	3,575
Long-Term Debt	749	875	1,751	2,031	2,315	2,126	2,979	2,555	2,756
Asset Retirement Reserve & Litigation Obligation	11	141	215	207	145	148	153	147	58
Noncurrent Deferred & Payable Income Tax Liabilities	76	200	210	268	256	215	267	264	215
Other Noncurrent Operating Liabilities	26	83	113	320	390	184	638	526	546
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	34	0.00
Total Equity & Noncontrolling Interests	1,183	1,964	1,808	1,835	1,125	1,014	1,070	960	575
Total Preferred & Common Equity	992	1,651	1,633	1,666	1,007	894	944	846	313
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	992	1,651	1,633	1,666	1,007	894	944	846	313
Common Stock	651	901	1,136	1,153	1,186	1,207	1,135	1,114	1,217
Retained Earnings	522	768	982	1,206	522	385	508	430	-206
Treasury Stock	-161	-25	-514	-692	-694	-694	-694	-694	-694
Accumulated Other Comprehensive Income / (Loss)	-21	6.90	29	0.10	-7.20	-3.80	-5.20	-4.80	-4.10
Noncontrolling Interest	191	314	176	169	118	120	126	114	262

This table presents Delek US's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	8,397	7,787	7,770	7,869	7,180	6,944	7,030
Total Current Assets	4,030	3,187	3,196	3,333	2,708	2,501	2,565
Cash & Equivalents	1,154	865	822	902	753	658	1,038
Accounts Receivable	1,036	848	1,004	1,167	832	771	562
Inventories, net	1,634	1,315	1,276	1,179	1,038	1,010	915
Other Current Assets	206	159	95	86	85	61	51
Other Current Nonoperating Assets	-	-	-	-	-	-	0.00
Plant, Property, & Equipment, net	2,678	2,882	2,869	2,835	2,804	2,786	2,829
Plant, Property & Equipment, gross	4,192	4,529	4,577	4,603	4,736	4,799	4,791
Accumulated Depreciation	1,514	1,647	1,708	1,768	1,932	2,014	1,962
Total Noncurrent Assets	1,689	1,718	1,704	1,701	1,668	1,657	1,637
Long-Term Investments	361	354	364	371	370	387	409
Goodwill	744	744	744	744	729	729	688
Intangible Assets	321	310	305	300	291	284	329
Other Noncurrent Operating Assets	264	309	291	285	277	256	212
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	0.00
Total Liabilities & Shareholders' Equity	8,397	7,787	7,770	7,869	7,180	6,944	7,030
Total Liabilities	7,114	6,662	6,707	6,712	6,145	5,961	6,085
Total Current Liabilities	3,829	2,870	2,915	3,003	2,607	2,565	2,467
Short-Term Debt	63	50	50	30	15	9.50	9.50
Accounts Payable	2,150	1,794	1,990	2,007	1,732	1,861	1,714
Other Current Liabilities	1,616	1,026	875	966	860	694	744
Other Current Nonoperating Liabilities	-	-	-	-	-	-	0.00
Total Noncurrent Liabilities	3,285	3,793	3,792	3,709	3,539	3,396	3,618
Long-Term Debt	2,671	2,726	2,761	2,609	2,482	2,452	2,780
Asset Retirement Reserve & Litigation Obligation	153	154	154	155	154	59	58
Noncurrent Deferred & Payable Income Tax Liabilities	310	284	281	304	270	262	244
Other Noncurrent Operating Liabilities	151	630	596	642	633	623	536
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	70
Total Equity & Noncontrolling Interests	1,283	1,124	1,063	1,157	1,035	983	875
Total Preferred & Common Equity	1,160	1,000	941	1,038	855	806	703
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,160	1,000	941	1,038	855	806	703
Common Stock	1,127	1,142	1,123	1,117	1,173	1,177	1,174
Retained Earnings	732	557	518	620	382	328	229
Treasury Stock	-694	-694	-694	-694	-694	-694	-694
Accumulated Other Comprehensive Income / (Loss)	-4.00	-5.20	-5.30	-5.30	-4.80	-4.80	-4.80
Noncontrolling Interest	123	124	122	119	180	177	172

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-12.21%	73.11%	40.81%	-9.14%	-21.47%	45.83%	85.96%	-16.84%	-28.03%
EBITDA Growth	0.00%	-60.92%	651.49%	51.83%	-15.15%	-159.25%	160.76%	199.10%	-20.00%	-118.83%
EBIT Growth	0.00%	-170.55%	859.07%	60.69%	-19.31%	-237.65%	97.19%	2,533.33%	-45.99%	-295.33%
NOPAT Growth	0.00%	-128.78%	674.59%	144.31%	-16.30%	-226.68%	95.26%	1,653.38%	-23.43%	-219.08%
Net Income Growth	0.00%	-405.26%	341.83%	16.21%	-10.32%	-270.67%	83.39%	404.83%	-83.92%	-1,215.42%
EPS Growth	0.00%	-878.13%	260.64%	-1.25%	2.78%	-304.68%	79.18%	307.51%	-91.64%	-3,023.33%
Operating Cash Flow Growth	0.00%	37.78%	28.91%	75.26%	2.66%	-149.18%	231.28%	14.51%	138.33%	-106.59%
Free Cash Flow Firm Growth	0.00%	0.00%	-14.10%	135.69%	-39.47%	-219.69%	190.35%	-292.53%	306.03%	-138.07%
Invested Capital Growth	0.00%	0.00%	138.65%	3.30%	6.63%	-8.56%	-12.53%	43.85%	-26.32%	2.73%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	-0.09%	-2.01%	-5.21%	13.01%	4.91%	-4.42%	-14.49%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	10.16%	-17.05%	-397.42%	422.44%	-18.25%	-7.94%	-163.51%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	12.89%	-21.65%	-119.39%	94.78%	-25.92%	-18.72%	-142.24%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-23.36%	-18.29%	-100.25%	90.82%	-22.80%	-6.94%	-144.77%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-20.67%	-21.01%	-131.93%	74.83%	-26.47%	-51.91%	-86.77%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-29.08%	-20.39%	-117.54%	68.94%	-29.19%	-73.68%	-83.47%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	60.73%	24.93%	-28.77%	-3.63%	13.54%	-51.52%	60.38%	-135.63%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-52.32%	37.53%	-38.52%	-38,575.05%	264.09%	-532.88%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-5.44%	1.73%	-14.41%	0.82%	16.79%	-14.63%	-3.35%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	11.40%	0.76%	5.94%	9.51%	9.57%	-3.57%	2.35%	3.78%	3.33%	-0.36%
EBITDA Margin	3.77%	1.68%	7.29%	7.86%	7.34%	-5.54%	2.31%	3.71%	3.57%	-0.93%
Operating Margin	1.44%	-1.17%	2.48%	5.98%	5.29%	-10.03%	-0.33%	2.31%	1.49%	-4.15%
EBIT Margin	1.47%	-1.18%	5.18%	5.91%	5.25%	-9.20%	-0.18%	2.32%	1.51%	-4.09%
Profit (Net Income) Margin	0.91%	-3.18%	4.44%	3.66%	3.62%	-7.86%	-0.90%	1.47%	0.28%	-4.40%
Tax Burden Percent	205.16%	34.10%	107.78%	77.22%	83.49%	74.77%	69.41%	90.27%	281.33%	73.78%
Interest Burden Percent	30.30%	788.71%	79.50%	80.25%	82.49%	114.20%	726.46%	69.97%	6.68%	145.51%
Effective Tax Rate	-74.18%	0.00%	-9.76%	20.99%	17.80%	0.00%	0.00%	17.53%	-18.07%	0.00%
Return on Invested Capital (ROIC)	0.00%	-7.13%	12.10%	20.63%	16.44%	-21.09%	-1.12%	15.23%	11.39%	-15.76%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	84.37%	211.15%	-3.10%	5.73%	-27.52%	-7.53%	9.18%	-4.52%	-28.26%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-15.43%	8.41%	-0.75%	2.01%	-17.68%	-7.79%	12.65%	-6.78%	-52.11%
Return on Equity (ROE)	0.00%	-22.56%	20.50%	19.88%	18.46%	-38.77%	-8.91%	27.89%	4.60%	-67.87%
Cash Return on Invested Capital (CROIC)	0.00%	-207.13%	-69.79%	17.39%	10.02%	-12.14%	12.25%	-20.73%	41.69%	-18.45%
Operating Return on Assets (OROA)	0.00%	-1.66%	8.45%	10.35%	7.64%	-10.22%	-0.29%	6.13%	3.23%	-7.01%
Return on Assets (ROA)	0.00%	-4.48%	7.24%	6.41%	5.26%	-8.73%	-1.47%	3.87%	0.61%	-7.53%
Return on Common Equity (ROCE)	0.00%	-18.93%	17.22%	17.30%	16.71%	-35.00%	-7.92%	24.60%	4.06%	-51.22%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-13.45%	19.54%	22.96%	20.18%	-57.00%	-10.66%	30.79%	5.52%	-166.53%
Net Operating Profit after Tax (NOPAT)	120	-34	198	483	405	-513	-24	377	289	-344
NOPAT Margin	2.50%	-0.82%	2.72%	4.72%	4.35%	-7.02%	-0.23%	1.91%	1.75%	-2.90%
Net Nonoperating Expense Percent (NNEP)	0.00%	-91.50%	-199.06%	23.72%	10.71%	6.44%	6.41%	6.05%	15.90%	12.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.15%	8.12%	-10.30%
Cost of Revenue to Revenue	88.60%	99.24%	94.06%	90.49%	90.43%	103.57%	97.65%	96.22%	96.67%	100.36%
SG&A Expenses to Revenue	7.76%	2.53%	2.42%	2.42%	2.95%	3.21%	1.88%	1.58%	1.65%	2.13%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.96%	1.93%	3.46%	3.53%	4.28%	6.45%	2.68%	1.47%	1.84%	3.78%
Earnings before Interest and Taxes (EBIT)	70	-50	377	605	488	-672	-19	460	248	-485
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	180	71	530	804	683	-404	246	735	588	-111
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	1.42	1.37	1.30	1.08	1.14	1.84	1.86	3.74
Price to Tangible Book Value (P/TBV)	0.00	0.00	3.19	3.34	3.09	6.40	16.42	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.32	0.22	0.23	0.15	0.10	0.09	0.10	0.10
Price to Earnings (P/E)	0.00	0.00	8.10	6.58	6.96	0.00	0.00	6.74	79.62	0.00
Dividend Yield	3.68%	3.11%	2.09%	3.52%	3.92%	8.38%	0.00%	2.45%	3.75%	5.43%
Earnings Yield	0.00%	0.00%	12.35%	15.20%	14.38%	0.00%	0.00%	14.84%	1.26%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.32	1.25	1.19	1.03	1.06	1.27	1.44	1.39
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.42	0.29	0.33	0.33	0.20	0.19	0.19	0.26
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	5.75	3.71	4.45	0.00	8.76	5.05	5.29	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	8.10	4.94	6.21	0.00	0.00	8.07	12.51	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	15.40	6.18	7.50	0.00	0.00	9.83	10.76	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	9.53	5.33	5.27	0.00	5.80	8.73	3.07	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	7.33	12.30	0.00	8.07	0.00	2.94	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.70	0.75	0.99	1.13	2.09	2.19	2.86	2.71	4.81
Long-Term Debt to Equity	0.00	0.63	0.45	0.97	1.11	2.06	2.10	2.79	2.66	4.79
Financial Leverage	0.00	-0.18	0.04	0.24	0.35	0.64	1.04	1.38	1.50	1.84
Leverage Ratio	0.00	2.52	2.83	3.10	3.51	4.44	6.05	7.20	7.57	9.02
Compound Leverage Factor	0.00	19.87	2.25	2.49	2.89	5.07	43.97	5.04	0.51	13.12
Debt to Total Capital	0.00%	41.33%	42.73%	49.65%	52.97%	67.61%	68.63%	74.06%	73.04%	82.78%
Short-Term Debt to Total Capital	0.00%	4.19%	17.21%	0.89%	0.93%	0.96%	2.85%	1.81%	1.25%	0.28%
Long-Term Debt to Total Capital	0.00%	37.14%	25.52%	48.76%	52.04%	66.65%	65.77%	72.25%	71.79%	82.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	9.46%	9.14%	4.89%	4.33%	3.41%	3.71%	3.05%	3.21%	7.86%
Common Equity to Total Capital	0.00%	49.22%	48.13%	45.46%	42.70%	28.98%	27.67%	22.89%	23.75%	9.36%
Debt to EBITDA	0.00	11.81	2.77	2.22	3.03	-5.81	9.03	4.16	4.42	-24.98
Net Debt to EBITDA	0.00	-3.07	0.75	0.71	1.03	-2.96	4.14	2.52	2.41	-14.79
Long-Term Debt to EBITDA	0.00	10.62	1.65	2.18	2.98	-5.72	8.65	4.05	4.35	-24.89
Debt to NOPAT	0.00	-24.18	7.41	3.69	5.11	-4.58	-91.31	8.09	9.00	-8.04
Net Debt to NOPAT	0.00	6.28	2.00	1.19	1.74	-2.34	-41.89	4.91	4.91	-4.76
Long-Term Debt to NOPAT	0.00	-21.73	4.42	3.62	5.02	-4.52	-87.52	7.90	8.84	-8.01
Altman Z-Score	0.00	0.00	1.96	2.86	2.15	1.16	1.72	2.93	2.64	1.58
Noncontrolling Interest Sharing Ratio	0.00%	16.12%	16.02%	12.97%	9.46%	9.71%	11.14%	11.79%	11.83%	24.54%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.49	0.98	1.45	1.26	1.21	0.97	1.20	0.99	0.93
Quick Ratio	0.00	1.02	0.57	0.96	0.74	0.69	0.52	0.67	0.60	0.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1,001	-1,142	407	247	-295	267	-513	1,058	-403
Operating Cash Flow to CapEx	96.51%	537.96%	185.98%	219.38%	144.96%	-105.09%	176.60%	151.89%	259.50%	-16.00%
Free Cash Flow to Firm to Interest Expense	0.00	-18.39	-12.17	3.02	1.88	-2.35	1.95	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	3.45	4.56	3.41	4.15	4.39	-2.25	2.72	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-0.12	3.71	1.58	2.26	1.36	-4.39	1.18	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.41	1.63	1.75	1.46	1.11	1.64	2.64	2.14	1.71
Accounts Receivable Turnover	0.00	15.78	17.15	18.67	14.23	11.06	16.33	19.69	16.32	16.92
Inventory Turnover	0.00	10.62	11.38	12.46	10.35	9.03	10.46	13.71	12.94	12.97
Fixed Asset Turnover	0.00	3.80	4.48	4.72	4.02	3.05	4.56	7.79	6.02	4.21
Accounts Payable Turnover	0.00	8.39	9.29	9.32	6.44	5.51	7.32	11.07	8.94	6.56
Days Sales Outstanding (DSO)	0.00	23.13	21.29	19.55	25.65	33.00	22.36	18.53	22.37	21.58
Days Inventory Outstanding (DIO)	0.00	34.38	32.06	29.29	35.26	40.41	34.90	26.62	28.20	28.14
Days Payable Outstanding (DPO)	0.00	43.49	39.29	39.15	56.67	66.21	49.84	32.96	40.81	55.66
Cash Conversion Cycle (CCC)	0.00	14.02	14.06	9.69	4.25	7.20	7.42	12.20	9.75	-5.94
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	966	2,306	2,382	2,540	2,322	2,031	2,922	2,153	2,212
Invested Capital Turnover	0.00	8.69	4.44	4.37	3.78	3.00	4.89	7.99	6.49	5.43
Increase / (Decrease) in Invested Capital	0.00	966	1,340	76	158	-217	-291	891	-769	59
Enterprise Value (EV)	0.00	0.00	3,048	2,987	3,034	2,398	2,152	3,711	3,108	3,068
Market Capitalization	0.00	0.00	2,339	2,238	2,160	1,082	1,015	1,732	1,577	1,169
Book Value per Share	$0.00	$16.02	$20.26	$19.92	$22.45	$13.65	$12.06	$13.54	$13.22	$4.95
Tangible Book Value per Share	$0.00	$15.39	$9.00	$8.18	$9.43	$2.30	$0.83	($1.67)	($2.03)	($7.66)
Total Capital	0.00	2,015	3,430	3,591	3,902	3,474	3,232	4,123	3,560	3,340
Total Debt	0.00	833	1,466	1,783	2,067	2,348	2,218	3,054	2,600	2,765
Total Long-Term Debt	0.00	749	875	1,751	2,031	2,315	2,126	2,979	2,555	2,756
Net Debt	0.00	-216	396	574	705	1,197	1,017	1,853	1,417	1,637
Capital Expenditures (CapEx)	187	46	172	255	397	269	210	280	391	418
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-143	-402	-291	-312	-358	-871	-136	-796	-910
Debt-free Net Working Capital (DFNWC)	0.00	546	530	789	644	430	-15	705	25	-175
Net Working Capital (NWC)	0.00	462	-60	757	607	396	-107	631	-19	-184
Net Nonoperating Expense (NNE)	76	99	-125	109	68	61	71	87	242	177
Net Nonoperating Obligations (NNO)	0.00	-216	342	574	705	1,197	1,017	1,853	1,194	1,637
Total Depreciation and Amortization (D&A)	110	120	153	199	194	268	265	275	340	375
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-3.41%	-5.52%	-2.84%	-3.35%	-4.90%	-8.18%	-0.69%	-4.84%	-7.68%
Debt-free Net Working Capital to Revenue	0.00%	13.01%	7.30%	7.71%	6.92%	5.88%	-0.14%	3.56%	0.15%	-1.47%
Net Working Capital to Revenue	0.00%	11.00%	-0.82%	7.40%	6.53%	5.43%	-1.00%	3.18%	-0.12%	-1.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$4.04	$0.00	$4.10	($8.26)	($2.75)	$3.63	$0.30	($8.77)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	71.57M	0.00	75.85M	73.60M	73.98M	70.79M	65.41M	63.88M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$4.00	$0.00	$4.06	($8.26)	($2.75)	$3.59	$0.30	($8.77)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	72.30M	0.00	76.57M	73.60M	73.98M	71.52M	65.98M	63.88M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	83.92M	0.00	73.41M	73.78M	74.20M	66.94M	64.02M	62.51M
Normalized Net Operating Profit after Tax (NOPAT)	48	-64	126	483	405	-424	-41	352	184	-188
Normalized NOPAT Margin	1.01%	-1.53%	1.74%	4.72%	4.35%	-5.81%	-0.38%	1.78%	1.12%	-1.59%
Pre Tax Income Margin	0.45%	-9.32%	4.12%	4.74%	4.33%	-10.51%	-1.29%	1.63%	0.10%	-5.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.35	-0.91	4.01	4.48	3.72	-5.35	-0.14	0.00	0.00	0.00
NOPAT to Interest Expense	2.30	-0.63	2.11	3.58	3.09	-4.08	-0.18	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-2.23	-1.76	2.18	2.59	0.70	-7.49	-1.68	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-1.28	-1.48	0.28	1.69	0.06	-6.22	-1.72	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	132.72%	-46.18%	26.97%	21.37%	25.82%	-17.08%	0.00%	27.13%	129.12%	-12.32%
Augmented Payout Ratio	229.29%	-50.67%	34.72%	118.81%	78.79%	-17.41%	0.00%	93.77%	311.99%	-20.29%

This table displays calculated financial ratios and metrics derived from Delek US's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	80.11%	29.81%	-11.99%	-29.87%	-13.07%	-7.83%	-17.75%	-18.45%	-34.27%	-41.90%
EBITDA Growth	5.06%	-174.95%	105.19%	-75.39%	131.04%	-9.39%	-44.88%	-24.03%	-110.43%	-308.84%
EBIT Growth	-10.05%	-648.79%	230.18%	-90.02%	291.25%	-18.44%	-77.72%	-72.78%	-157.78%	-154.78%
NOPAT Growth	37.62%	-642.00%	203.43%	-90.95%	302.27%	-18.30%	-80.46%	-73.05%	-149.55%	-159.39%
Net Income Growth	-18.45%	-2,050.98%	387.84%	-100.41%	710.12%	-45.94%	-134.90%	-1,640.00%	-149.60%	-151.16%
EPS Growth	-37.50%	-870.59%	955.56%	-102.57%	1,870.00%	-50.91%	-153.68%	-346.15%	-160.91%	-160.24%
Operating Cash Flow Growth	72.91%	-280.40%	1,374.25%	-82.99%	232.26%	131.22%	-57.81%	-150.89%	-104.99%	-280.07%
Free Cash Flow Firm Growth	-160.94%	-419.50%	-295.04%	41.00%	134.26%	166.64%	151.04%	405.80%	-2.65%	-153.25%
Invested Capital Growth	24.19%	43.85%	34.98%	5.19%	0.80%	-26.32%	-10.14%	-10.74%	-9.26%	2.73%
Revenue Q/Q Growth	-10.99%	-24.24%	-12.39%	6.91%	10.33%	-19.67%	-20.29%	6.01%	-11.09%	-28.99%
EBITDA Q/Q Growth	-77.59%	-155.53%	990.46%	-40.42%	110.43%	-126.29%	351.66%	-17.88%	-128.88%	-930.82%
EBIT Q/Q Growth	-89.19%	-353.45%	244.13%	-66.91%	323.59%	-176.73%	124.10%	-59.58%	-999.26%	-238.30%
NOPAT Q/Q Growth	-88.96%	-321.57%	261.71%	-70.07%	391.03%	-165.16%	123.75%	-58.72%	-1,002.96%	-241.10%
Net Income Q/Q Growth	-95.44%	-752.98%	165.82%	-102.08%	9,173.33%	-217.63%	84.26%	-3.57%	-158.62%	-495.70%
EPS Q/Q Growth	-98.02%	-1,750.00%	157.58%	-113.68%	1,615.38%	-226.40%	79.52%	-13.73%	-106.90%	-440.00%
Operating Cash Flow Q/Q Growth	-76.71%	-323.35%	235.87%	-75.93%	354.89%	-79.01%	83.59%	-129.03%	55.37%	-656.94%
Free Cash Flow Firm Q/Q Growth	-168.96%	-121.70%	40.06%	83.11%	256.16%	331.24%	-34.40%	1.21%	-50.29%	-335.89%
Invested Capital Q/Q Growth	-2.10%	16.79%	-8.28%	0.31%	-6.19%	-14.63%	1.33%	-0.36%	-4.63%	-3.35%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	2.65%	-3.46%	6.04%	3.76%	6.01%	-3.34%	4.03%	1.65%	-0.66%	-9.70%
EBITDA Margin	2.38%	-1.74%	5.95%	3.31%	6.32%	-2.07%	3.98%	3.09%	-1.00%	-14.55%
Operating Margin	1.00%	-3.36%	3.64%	1.19%	4.58%	-4.31%	1.01%	0.39%	-4.01%	-19.25%
EBIT Margin	1.01%	-3.37%	3.82%	1.18%	4.54%	-4.34%	1.03%	0.39%	-3.99%	-19.01%
Profit (Net Income) Margin	0.32%	-2.72%	1.84%	-0.04%	2.94%	-4.31%	-0.78%	-0.76%	-2.22%	-18.61%
Tax Burden Percent	80.77%	59.01%	82.05%	28.30%	87.98%	72.51%	77.78%	77.22%	38.55%	86.53%
Interest Burden Percent	38.73%	136.59%	58.71%	-10.69%	73.63%	136.97%	-97.01%	-250.37%	144.23%	113.15%
Effective Tax Rate	19.23%	0.00%	17.95%	0.00%	18.81%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	6.72%	-18.80%	25.23%	5.71%	25.51%	-19.58%	4.52%	1.68%	-16.16%	-73.16%
ROIC Less NNEP Spread (ROIC-NNEP)	4.41%	-19.83%	21.72%	3.14%	22.72%	-22.73%	1.24%	-0.66%	-14.85%	-81.01%
Return on Net Nonoperating Assets (RNNOA)	4.41%	-27.32%	26.56%	3.72%	24.06%	-34.12%	1.68%	-0.98%	-19.12%	-149.37%
Return on Equity (ROE)	11.12%	-46.11%	51.79%	9.44%	49.58%	-53.70%	6.20%	0.70%	-35.28%	-222.52%
Cash Return on Invested Capital (CROIC)	0.06%	-20.73%	-9.20%	-1.26%	11.57%	41.69%	15.35%	15.02%	3.87%	-18.45%
Operating Return on Assets (OROA)	2.51%	-8.90%	9.57%	2.54%	9.61%	-9.29%	2.24%	0.83%	-7.42%	-32.56%
Return on Assets (ROA)	0.79%	-7.18%	4.61%	-0.08%	6.23%	-9.23%	-1.69%	-1.60%	-4.13%	-31.88%
Return on Common Equity (ROCE)	9.93%	-40.67%	45.65%	8.48%	44.66%	-47.34%	5.33%	0.59%	-29.22%	-167.93%
Return on Equity Simple (ROE_SIMPLE)	34.05%	0.00%	34.79%	-2.36%	9.36%	0.00%	-5.93%	-9.34%	-39.67%	0.00%
Net Operating Profit after Tax (NOPAT)	43	-95	117	35	172	-112	23	9.45	-85	-291
NOPAT Margin	0.80%	-2.35%	2.99%	0.84%	3.72%	-3.02%	0.71%	0.28%	-2.80%	-13.47%
Net Nonoperating Expense Percent (NNEP)	2.31%	1.03%	3.50%	2.57%	2.79%	3.14%	3.28%	2.34%	-1.32%	7.85%
Return On Investment Capital (ROIC_SIMPLE)	-	-2.30%	-	-	-	-3.15%	-	-	-	-8.71%
Cost of Revenue to Revenue	97.35%	103.46%	93.96%	96.24%	93.99%	103.34%	95.97%	98.35%	100.66%	109.70%
SG&A Expenses to Revenue	1.11%	2.03%	1.82%	1.81%	1.46%	1.53%	2.00%	1.84%	2.31%	2.54%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	1.65%	-0.10%	2.40%	2.56%	1.42%	0.97%	3.02%	1.26%	3.34%	9.55%
Earnings before Interest and Taxes (EBIT)	54	-136	150	50	210	-161	33	14	-121	-411
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	127	-70	233	139	293	-77	129	106	-31	-314
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.54	1.84	1.45	1.59	1.70	1.86	2.25	1.95	1.72	3.74
Price to Tangible Book Value (P/TBV)	18.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.09	0.09	0.07	0.08	0.10	0.10	0.12	0.10	0.09	0.10
Price to Earnings (P/E)	4.93	6.74	4.60	0.00	26.78	79.62	0.00	0.00	0.00	0.00
Dividend Yield	1.59%	2.45%	3.84%	4.65%	4.02%	3.75%	3.89%	3.97%	5.28%	5.43%
Earnings Yield	20.26%	14.84%	21.76%	0.00%	3.73%	1.26%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.25	1.27	1.17	1.21	1.29	1.44	1.44	1.32	1.22	1.39
Enterprise Value to Revenue (EV/Rev)	0.17	0.19	0.16	0.18	0.19	0.19	0.21	0.20	0.20	0.26
Enterprise Value to EBITDA (EV/EBITDA)	3.48	5.05	3.48	6.87	5.09	5.29	6.55	6.36	16.04	0.00
Enterprise Value to EBIT (EV/EBIT)	5.04	8.07	5.24	21.75	10.64	12.51	20.78	24.10	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	6.40	9.83	6.52	32.56	10.47	10.76	29.25	33.91	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	3.57	8.73	3.94	9.85	5.15	3.07	4.43	4.93	14.91	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	2,345.50	0.00	0.00	0.00	11.19	2.94	8.90	8.28	30.05	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.13	2.86	2.47	2.64	2.28	2.71	2.41	2.50	2.95	4.81
Long-Term Debt to Equity	2.08	2.79	2.42	2.60	2.25	2.66	2.40	2.50	2.94	4.79
Financial Leverage	1.00	1.38	1.22	1.18	1.06	1.50	1.36	1.49	1.29	1.84
Leverage Ratio	6.71	7.20	7.50	6.96	6.67	7.57	6.93	7.19	7.09	9.02
Compound Leverage Factor	2.60	9.84	4.40	-0.74	4.91	10.37	-6.72	-18.01	10.22	10.20
Debt to Total Capital	68.06%	74.06%	71.17%	72.56%	69.51%	73.04%	70.69%	71.47%	74.69%	82.78%
Short-Term Debt to Total Capital	1.57%	1.81%	1.27%	1.28%	0.78%	1.25%	0.41%	0.28%	0.25%	0.28%
Long-Term Debt to Total Capital	66.49%	72.25%	69.90%	71.28%	68.74%	71.79%	70.28%	71.19%	74.43%	82.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	3.05%	3.05%	3.19%	3.14%	3.14%	3.21%	5.09%	5.14%	6.49%	7.86%
Common Equity to Total Capital	28.89%	22.89%	25.65%	24.30%	27.34%	23.75%	24.21%	23.39%	18.83%	9.36%
Debt to EBITDA	3.04	4.16	3.09	5.95	4.13	4.42	4.70	4.95	16.00	-24.98
Net Debt to EBITDA	1.36	2.52	1.73	3.44	2.14	2.41	2.59	2.85	7.71	-14.79
Long-Term Debt to EBITDA	2.97	4.05	3.03	5.84	4.08	4.35	4.68	4.93	15.95	-24.89
Debt to NOPAT	5.59	8.09	5.78	28.20	8.50	9.00	21.01	26.40	-19.84	-8.04
Net Debt to NOPAT	2.49	4.91	3.24	16.31	4.40	4.91	11.55	15.20	-9.56	-4.76
Long-Term Debt to NOPAT	5.46	7.90	5.68	27.70	8.40	8.84	20.89	26.30	-19.78	-8.01
Altman Z-Score	2.57	2.69	2.87	2.60	2.60	2.45	2.55	2.44	2.10	1.61
Noncontrolling Interest Sharing Ratio	10.69%	11.79%	11.85%	10.17%	9.92%	11.83%	14.09%	14.60%	17.20%	24.54%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.05	1.20	1.11	1.10	1.11	0.99	1.04	0.98	1.04	0.93
Quick Ratio	0.57	0.67	0.60	0.63	0.69	0.60	0.61	0.56	0.65	0.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-445	-986	-577	-98	152	657	295	298	148	-350
Operating Cash Flow to CapEx	137.63%	-328.96%	186.99%	143.44%	1,027.55%	126.82%	352.43%	-56.28%	-21.01%	-85.65%
Free Cash Flow to Firm to Interest Expense	-8.77	0.00	-7.55	-1.21	0.00	0.00	3.36	3.84	0.00	0.00
Operating Cash Flow to Interest Expense	2.57	0.00	5.16	1.18	0.00	0.00	1.90	-0.62	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.70	0.00	2.40	0.36	0.00	0.00	1.36	-1.73	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.49	2.64	2.51	2.15	2.12	2.14	2.17	2.10	1.86	1.71
Accounts Receivable Turnover	18.47	19.69	17.50	15.43	15.64	16.32	19.32	17.41	16.04	16.92
Inventory Turnover	13.14	13.71	12.70	11.27	11.75	12.94	13.28	13.07	13.04	12.97
Fixed Asset Turnover	7.56	7.79	7.65	6.48	6.25	6.02	5.71	5.46	4.89	4.21
Accounts Payable Turnover	9.35	11.07	8.60	7.82	7.95	8.94	8.86	7.76	7.34	6.56
Days Sales Outstanding (DSO)	19.76	18.53	20.86	23.65	23.33	22.37	18.90	20.97	22.76	21.58
Days Inventory Outstanding (DIO)	27.77	26.62	28.73	32.39	31.05	28.20	27.49	27.93	27.99	28.14
Days Payable Outstanding (DPO)	39.04	32.96	42.45	46.65	45.88	40.81	41.21	47.04	49.72	55.66
Cash Conversion Cycle (CCC)	8.48	12.20	7.14	9.39	8.50	9.75	5.18	1.86	1.02	-5.94
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,502	2,922	2,680	2,689	2,522	2,153	2,408	2,400	2,289	2,212
Invested Capital Turnover	8.36	7.99	8.45	6.84	6.86	6.49	6.38	6.07	5.76	5.43
Increase / (Decrease) in Invested Capital	487	891	695	133	20	-769	-272	-289	-234	59
Enterprise Value (EV)	3,130	3,711	3,127	3,245	3,252	3,108	3,477	3,162	2,795	3,068
Market Capitalization	1,788	1,732	1,447	1,498	1,767	1,577	1,924	1,568	1,210	1,169
Book Value per Share	$16.33	$13.54	$14.94	$14.32	$16.01	$13.22	$13.36	$12.56	$10.89	$4.95
Tangible Book Value per Share	$1.35	($1.67)	($0.82)	($1.64)	($0.11)	($2.03)	($2.58)	($3.24)	($4.85)	($7.66)
Total Capital	4,017	4,123	3,899	3,874	3,795	3,560	3,532	3,445	3,735	3,340
Total Debt	2,734	3,054	2,775	2,811	2,638	2,600	2,497	2,462	2,789	2,765
Total Long-Term Debt	2,671	2,979	2,726	2,761	2,609	2,555	2,482	2,452	2,780	2,756
Net Debt	1,219	1,853	1,556	1,626	1,365	1,417	1,373	1,417	1,343	1,637
Capital Expenditures (CapEx)	95	88	211	66	42	72	47	86	103	191
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-891	-136	-499	-491	-542	-796	-637	-712	-930	-910
Debt-free Net Working Capital (DFNWC)	263	705	367	331	360	25	116	-54	107	-175
Net Working Capital (NWC)	200	631	317	282	331	-19	102	-64	98	-184
Net Nonoperating Expense (NNE)	26	15	45	37	36	48	48	36	-18	111
Net Nonoperating Obligations (NNO)	1,219	1,853	1,556	1,626	1,365	1,194	1,373	1,417	1,343	1,637
Total Depreciation and Amortization (D&A)	73	66	83	89	82	84	95	92	91	96
Debt-free, Cash-free Net Working Capital to Revenue	-4.72%	-0.69%	-2.53%	-2.74%	-3.14%	-4.84%	-3.93%	-4.61%	-6.71%	-7.68%
Debt-free Net Working Capital to Revenue	1.39%	3.56%	1.86%	1.85%	2.09%	0.15%	0.72%	-0.35%	0.77%	-1.47%
Net Working Capital to Revenue	1.06%	3.18%	1.61%	1.57%	1.92%	-0.12%	0.63%	-0.41%	0.71%	-1.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.11	($1.68)	$0.96	($0.13)	$1.98	($2.51)	($0.51)	($0.58)	($1.20)	($6.48)
Adjusted Weighted Average Basic Shares Outstanding	69.69M	70.79M	66.95M	65.77M	64.89M	65.41M	64.02M	64.21M	64.06M	63.88M
Adjusted Diluted Earnings per Share	$0.10	($1.65)	$0.95	($0.13)	$1.97	($2.49)	($0.51)	($0.58)	($1.20)	($6.48)
Adjusted Weighted Average Diluted Shares Outstanding	69.69M	71.52M	67.37M	65.77M	65.46M	65.41M	64.02M	64.21M	64.06M	63.88M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	69.69M	66.94M	65.73M	64.82M	63.93M	64.02M	64.13M	64.54M	63.20M	62.51M
Normalized Net Operating Profit after Tax (NOPAT)	43	-95	117	35	172	-112	23	25	-79	-291
Normalized NOPAT Margin	0.80%	-2.35%	2.99%	0.84%	3.72%	-3.02%	0.71%	0.73%	-2.59%	-13.47%
Pre Tax Income Margin	0.39%	-4.61%	2.24%	-0.13%	3.34%	-5.94%	-1.00%	-0.99%	-5.76%	-21.51%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.06	0.00	1.96	0.62	0.00	0.00	0.38	0.17	0.00	0.00
NOPAT to Interest Expense	0.84	0.00	1.53	0.44	0.00	0.00	0.26	0.12	0.00	0.00
EBIT Less CapEx to Interest Expense	-0.81	0.00	-0.80	-0.21	0.00	0.00	-0.16	-0.93	0.00	0.00
NOPAT Less CapEx to Interest Expense	-1.02	0.00	-1.23	-0.39	0.00	0.00	-0.28	-0.99	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	7.16%	27.13%	27.11%	-574.77%	98.25%	129.12%	-121.50%	-57.37%	-22.77%	-12.32%
Augmented Payout Ratio	33.49%	93.77%	64.47%	-1,340.54%	257.88%	311.99%	-289.15%	-117.13%	-37.11%	-20.29%

Frequently Asked Questions About Delek US's Financials

When does Delek US's fiscal year end?

According to the most recent income statement we have on file, Delek US's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Delek US's net income changed over the last 9 years?

Delek US's net income appears to be on a downward trend, with a most recent value of -$520.90 million in 2024, falling from $43.70 million in 2015. The previous period was $46.70 million in 2023. See Delek US's forecast for analyst expectations on what’s next for the company.

What is Delek US's operating income?

Delek US's total operating income in 2024 was -$491.50 million, based on the following breakdown:

Total Gross Profit: -$43.10 million
Total Operating Expenses: $448.40 million

How has Delek US revenue changed over the last 9 years?

Over the last 9 years, Delek US's total revenue changed from $4.78 billion in 2015 to $11.85 billion in 2024, a change of 147.9%.

How much debt does Delek US have?

Delek US's total liabilities were at $6.09 billion at the end of 2024, a 2.0% decrease from 2023, and a 238.9% increase since 2016.

How much cash does Delek US have?

In the past 8 years, Delek US's cash and equivalents has ranged from $689.20 million in 2016 to $1.08 billion in 2018, and is currently $735.60 million as of their latest financial filing in 2024.

How has Delek US's book value per share changed over the last 9 years?

Over the last 9 years, Delek US's book value per share changed from 0.00 in 2015 to 4.95 in 2024, a change of 495.0%.

Related Companies

This page (NYSE:DK) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Delek US (DK) Financials

Frequently Asked Questions About Delek US's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Delek US (DK) Financials

Annual Income Statements for Delek US

Quarterly Income Statements for Delek US

Annual Cash Flow Statements for Delek US

Quarterly Cash Flow Statements for Delek US

Annual Balance Sheets for Delek US

Quarterly Balance Sheets for Delek US

Annual Metrics and Ratios for Delek US

Quarterly Metrics and Ratios for Delek US

Frequently Asked Questions About Delek US's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools